- MKD31.35bn
- MKD34.63bn
- MKD20.90bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.06 | ||
| Price to Tang. Book | 2.47 | ||
| Price to Free Cashflow | 51.05 | ||
| Price to Sales | 1.43 | ||
| EV to EBITDA | 10.03 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.31% | ||
| Return on Equity | 12.4% | ||
| Operating Margin | 10.64% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | MKDm | 12,794.18 | 14,289.05 | 16,512.98 | 19,005.7 | 20,899.12 | n/a | n/a | 11.49% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +1.94 | -16.13 | +7.75 | +6.79 | +6.64 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Alkaloid AD Skopje is a Macedonia-based company active in the pharmaceutical sector. It is engaged in the manufacturing and distribution of pharmaceuticals, the processing of herbal materials and the production of cosmetics, tea, chemical products and coating agents. It operates through two divisions: Pharmaceuticals, and Chemicals, Cosmetics and Botanicals. The Company’s product range includes human drugs, x-ray films, haemodialysis solutions, pharmaceutical raw materials, animal health products, perfumes, household cosmetics, skin, teeth and hair care products, tea and alimentary products. It also operates a development institute for analysis, research and quality control, warehouses and laboratories. The Company operates more than 13 subsidiaries in such countries as Croatia, Serbia, Slovenia, Bosnia and Herzegovina, Bulgaria, Kosovo, the Untied States, Montenegro and the Russian Federation.
Directors
- Miodrag Micajkov CSU (74)
- Ilija Djonov SUB (74)
- Zivko Mukaetov CMG (44)
- Gjorgji Jovanov COO (54)
- Viktor Stojcevski CFO (43)
- Dejan Krzhovski CIN
- Nikola Dimovski CIO
- Dushko Markovski DMK
- Nikola Kolevski CCO
- Oliver Lazareski CEX
- Natasa Nikolvska VBD
- Lidija Sofrevska-Andonova IND
- Last Annual
- December 31st, 2025
- Last Interim
- September 30th, 2026
- Incorporated
- December 31st, 1990
- Public Since
- January 1st, 1996
- No. of Employees
- 3,018
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Macedonian Stock Exchange- Shares in Issue
- 1,408,796
- Address
- Aleksandar Makedonski 12, SKOPJE, 1000
- Web
- https://alkaloid.com.mk/
- Phone
- +389 23104000
- Auditors
- PricewaterhouseCoopers Audit
Upcoming Events for ALK
Similar to ALK
Replek AD Skopje
Macedonian Stock Exchange
FAQ
As of Today at 18:11 UTC, shares in Alkaloid AD Skopje are trading at MKD22,250.00. This share price information is delayed by 15 minutes.
Shares in Alkaloid AD Skopje last closed at MKD22,250.00 and the price had moved by -12.75% over the past 365 days. In terms of relative price strength the Alkaloid AD Skopje share price has underperformed the FTSE Global All Cap Index by -24.02% over the past year.
The overall consensus recommendation for Alkaloid AD Skopje is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Alkaloid AD Skopje dividend yield is 3.24% based on the trailing twelve month period.
Last year, Alkaloid AD Skopje paid a total dividend of MKD720.00, and it currently has a trailing dividend yield of 3.24%. We do not have any data on when Alkaloid AD Skopje is to next pay dividends.
We do not have data on when Alkaloid AD Skopje is to next pay dividends. The historic dividend yield on Alkaloid AD Skopje shares is currently 3.24%.
To buy shares in Alkaloid AD Skopje you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of MKD22,250.00, shares in Alkaloid AD Skopje had a market capitalisation of MKD31.35bn.
Here are the trading details for Alkaloid AD Skopje:
- Country of listing: Macedonia
- Exchange: MKE
- Ticker Symbol: ALK
Based on an overall assessment of its quality, value and momentum Alkaloid AD Skopje is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Alkaloid AD Skopje is MKD18,763.00. That is 15.67% below the last closing price of MKD22,250.00.
Analysts covering Alkaloid AD Skopje currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Alkaloid AD Skopje. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -17.22%.
As of the last closing price of MKD22,250.00, shares in Alkaloid AD Skopje were trading -7.77% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Alkaloid AD Skopje PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at MKD22,250.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Alkaloid AD Skopje's management team is headed by:
- Miodrag Micajkov - CSU
- Ilija Djonov - SUB
- Zivko Mukaetov - CMG
- Gjorgji Jovanov - COO
- Viktor Stojcevski - CFO
- Dejan Krzhovski - CIN
- Nikola Dimovski - CIO
- Dushko Markovski - DMK
- Nikola Kolevski - CCO
- Oliver Lazareski - CEX
- Natasa Nikolvska - VBD
- Lidija Sofrevska-Andonova - IND